EIC Summit 2026: What EIC Business Acceleration Services will actually offer on 2–4 June in Brussels
- ›EIC Summit 2026 runs 3–4 June at Tour and Taxis in Brussels with BAS side events on 2 June.
- ›EIC BAS will stage targeted workshops, corporate and procurer matchmaking, and an international partners area.
- ›Life sciences matchmaking features AstraZeneca, Bayer, Chiesi and Coloplast, with Siemens Healthineers observing.
- ›A procurement pitch session focuses on remote monitoring and continuous patient care with buyers such as EpiCURA.
- ›Separate registration tracks apply and some calls are already closed or capacity limited.
EIC BAS at the EIC Summit 2026: the practical offer and where it fits
The European Innovation Council Summit returns to Brussels on 3–4 June 2026 at Tour and Taxis, with the EIC Business Acceleration Services layering a set of hands-on sessions, partner showcases and side events on top of the mainstage debates and exhibition. BAS positions these activities as tools to move awardees from research outputs toward commercial traction. In practice this means curated training, investor and buyer matchmaking, and formats that try to shorten time to first deals. It is not a substitute for funding but a set of channels that can help companies facing Europe’s familiar market fragmentation and scale challenges.
2 June: side events that set the stage
BAS kicks off the Summit week with four side events on 2 June in Brussels aimed at skills building and ecosystem connectivity. These are positioned as preparatory or thematic touchpoints rather than deal rooms.
| Side event | Audience and format | Status |
| ESG training by the EIC Community Programme | In-person training on Environmental, Social and Governance implementation for start-ups | Open call to launch soon |
| EIC Women Leadership Programme cohort kick-off and alumni gathering | Invitation-only launch for a new cohort and alumni networking | Invitation only |
| EIC Ecosystem Partners Day | Networking with the EIC’s wider partner network | Details forthcoming |
| Drone Innovation Forum | Showcase of EIC-backed drone innovators and discussion of sector issues | Details forthcoming |
3 June: workshops and what they actually cover
BAS will dedicate the morning of 3 June to practical workshops. Several sessions run in parallel, so attendees will need to prioritise. The topics mirror recurring bottlenecks for EU deep tech firms such as capital strategy, internationalisation, procurement and corporate venturing, plus a session on building gender-diverse leadership teams.
| Time | Session 1 | Session 2 |
| 10:00–10:30 | EIC Business Acceleration Services: Discover EIC support beyond funding! | Working with US and international co-investors: What does it take? |
| 10:30–11:00 | Scaling Smart: Stage-by-stage capital strategy | Going global: Turning market access into scalable growth |
| 11:00–13:00 | Innovation Procurement as a Superpower: Scaling breakthrough solutions across borders | Life sciences EIC Multicorporate Day: Pitching and fireside chat on corporate venturing |
| 11:30–12:30 | Companies with gender-diverse leadership teams are set to win, but how do you build one? | — |
Matchmaking tracks: where deals could start but are not guaranteed
Life sciences multi-corporate day
BAS will convene a life sciences Multi-Corporate Day on 3 June with AstraZeneca, Bayer, Chiesi and Coloplast. Siemens Healthineers will participate as an observing corporation. Selected EIC-backed companies pitch and join matching meetings with corporate experts and decision-makers. According to the related open call, selection is driven by corporate strategic fit and requires C-level participation from start-ups. Preparation typically includes mentoring, pitch dry runs and business proposal reviews. Applications for this cohort are closed.
| Corporate | Indicative themes drawn from the open call | Notes |
| AstraZeneca | Next-gen therapeutics and drug discovery technologies including new modalities and early discovery tools | Focus on delivery and sustainable chemistry approaches |
| Bayer | Transformative discovery and development tech including delivery innovation and AI in drug discovery | Interest in expanding druggable space |
| Chiesi | Respiratory diseases and neonatology with integrated care and disease-modifying approaches | Cross-cutting priority on health equity and access |
| Coloplast | Non-pharmacological bowel, bladder and stoma care solutions | Out of scope for drug-based approaches |
Matchmaking with procurers
A separate BAS track targets hospitals seeking solutions for remote monitoring and continuous patient care. Confirmed buyers include Belgian multi-site hospital group EpiCURA, with others to be announced. The window to apply is open until 24 April. Selected companies pitch at the Summit free of charge, but travel and accommodation are self-funded. Buyers will choose based on submitted pitch decks.
3–4 June: BAS stand and international partner booths
Across both Summit days, a dedicated exhibition area will include an EIC BAS stand and international partner booths from Canada, Japan, South Korea, Singapore and the United Arab Emirates. The BAS team will provide on-site guidance on the full services portfolio. International partners will showcase their ecosystems and collaboration pathways. These stands are networking points rather than funding desks, so companies should arrive with concise asks and materials aligned to market-entry questions.
Registration, capacity and practical caveats
A public registration link for the EIC Summit will be published in the coming weeks. Side events and matchmaking activities require separate applications and may have independent eligibility filters or limited capacity. Some calls are already closed and some sessions overlap. For activities that involve private buyers or corporate partners, non-selection typically comes without feedback. Several tracks require companies to cover their own travel and accommodation. BAS often issues short post-event and six-month impact surveys. Failure to complete them can affect future eligibility.
Key dates and what to prepare
| Date or deadline | Activity | Notes |
| 20 April 2026 | Planned opening of ESG training call | EIC Community training on 2 June, limited to about 30 participants |
| 11 May 2026 | Planned close of ESG training call | Selection based on fit and capacity |
| 24 April 2026 | Deadline to apply for hospital procurement pitching | Remote monitoring and continuous patient care focus |
| 22 March 2026 | Life sciences Multi-Corporate Day application deadline | Closed; preparation and selection already underway |
| 2 June 2026 | BAS side events in Brussels | ESG training, Women Leadership Programme gathering, Partners Day, Drone Forum |
| 3–4 June 2026 | EIC Summit main programme | Workshops and stands on 3 June, exhibition and partner booths run both days |
Why this matters for EU innovators and what to watch for
For many EIC-backed companies, the persistent gaps are not only capital but first customers, regulatory navigation and international scale. BAS is attempting to engineer these collisions with buyers, corporates and co-investors. The upside is faster discovery of fit or no-fit. The risk is that expectations overshoot and selection bottlenecks leave capable firms waiting. Companies should treat each format as an entry point into longer processes and prepare evidence that speaks the language of each counterpart, whether it is growth-stage investors, clinical buyers or corporate venturing units.